Corient Capital Partners LLC Has $3.19 Million Holdings in Express Scripts Holding (ESRX)
Corient Capital Partners LLC raised its stake in shares of Express Scripts Holding (NASDAQ:ESRX) by 4.8% in the fourth quarter, HoldingsChannel.com reports. The fund owned 42,691 shares of the company’s stock after acquiring an additional 1,936 shares during the period. Corient Capital Partners LLC’s holdings in Express Scripts were worth $3,186,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently modified their holdings of the company. SeaCrest Wealth Management LLC bought a new position in shares of Express Scripts during the fourth quarter valued at $105,000. Aevitas Wealth Management Inc. bought a new position in shares of Express Scripts during the fourth quarter valued at $128,000. Financial Gravity Companies Inc. bought a new position in shares of Express Scripts during the fourth quarter valued at $142,000. Bank of Nova Scotia Trust Co. bought a new position in shares of Express Scripts during the third quarter valued at $120,000. Finally, Monroe Bank & Trust MI lifted its holdings in shares of Express Scripts by 74.8% during the third quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock valued at $156,000 after acquiring an additional 970 shares during the period. 86.45% of the stock is owned by institutional investors.
Shares of Express Scripts Holding (ESRX) opened at $74.77 on Friday. The company has a quick ratio of 0.61, a current ratio of 0.67 and a debt-to-equity ratio of 0.83. The company has a market capitalization of $42,196.22, a PE ratio of 10.50, a P/E/G ratio of 0.92 and a beta of 0.94. Express Scripts Holding has a 12-month low of $55.80 and a 12-month high of $83.49.
Express Scripts announced that its Board of Directors has approved a share buyback program on Monday, December 18th that permits the company to repurchase 45,000,000 shares. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s leadership believes its shares are undervalued.
A number of research firms recently issued reports on ESRX. Bank of America began coverage on Express Scripts in a report on Tuesday, February 27th. They issued an “underperform” rating and a $77.00 price target for the company. Maxim Group reaffirmed a “buy” rating and issued a $87.00 price target on shares of Express Scripts in a report on Monday, February 26th. Jefferies Group set a $91.00 price target on Express Scripts and gave the company a “buy” rating in a report on Wednesday. Zacks Investment Research raised Express Scripts from a “hold” rating to a “buy” rating and set a $82.00 price target for the company in a report on Wednesday, February 14th. Finally, BidaskClub raised Express Scripts from a “hold” rating to a “buy” rating in a report on Friday, February 23rd. Six analysts have rated the stock with a sell rating, seven have given a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $80.49.
In related news, VP Glen D. Stettin sold 3,448 shares of Express Scripts stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $76.00, for a total value of $262,048.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Glen D. Stettin sold 3,449 shares of Express Scripts stock in a transaction dated Thursday, January 11th. The stock was sold at an average price of $81.00, for a total value of $279,369.00. Following the completion of the sale, the vice president now owns 33,715 shares of the company’s stock, valued at $2,730,915. The disclosure for this sale can be found here. Over the last quarter, insiders sold 21,896 shares of company stock valued at $1,617,903. Corporate insiders own 0.68% of the company’s stock.
Express Scripts Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.